1) Ezetimibe
依泽替米贝
1.
NPC1L1 contributes to the inhibition of lipid accumulation induced by ezetimibe in RAW264.7 cells
尼曼-匹克C1型类似蛋白1介导依泽替米贝对RAW264.7细胞脂质蓄积的抑制作用
2.
The Effect of Ezetimibe on the Expressions of ABCA1 and LXRα in Loaded-Lipid Cells Derived From Vascular Smooth Muscle Cell
依泽替米贝对血管平滑肌源性荷脂细胞三磷酸腺苷结合盒转运体A1和肝X受体α表达的影响
3.
The present paper reviews the pharmacological mechanism,pharmacokinetics of ezetimibe monotherapy and the combination therapy with statins in the treatment of hypercholesterolemia.
依泽替米贝是新型选择性胆固醇吸收抑制剂,现对其作用机制、药动学及临床单独使用或与他汀类 药物联用治疗高胆固醇血症的研究进展进行综述。
2) ezetimibe
依替米贝
1.
Study on the Synthesis of Intermediate of Ezetimibe;
依替米贝中间体合成研究
3) etimicin
依替米星
1.
The study of the stability of etimicin in different menstruums;
依替米星在不同溶媒中的稳定性研究
2.
Comparison of Clinical Effect and Safety of Etimicin and Amikacin;
依替米星与阿米卡星临床疗效及安全性比较
3.
A Meta-Analysis on Treatment of Bacterial Infections with Randomized Control Study of Etimicin versus Import Netilmicin;
依替米星与进口奈替米星随机对照治疗细菌感染的Meta分析
4) Etimicin sulfate
硫酸依替米星
1.
Determination of Etimicin Sulfate by Liquid Chromatography with Pulsed Amperometric Detection;
液相色谱-脉冲安培检测器法测定硫酸依替米星含量
2.
Resonance Rayleigh Scattering Spectra of Interaction of Netilmicin Sulfate and Etimicin Sulfate with Trypan Blue and Their Analytical Applications;
曲利本蓝与硫酸奈替米星和硫酸依替米星相互作用的共振瑞利散射光谱及分析应用
3.
Determination of Etimicin Sulfate by Pre-column Derivation HPLC;
HPLC柱前衍生化法测定硫酸依替米星的含量
5) etimicin hydrochloride
盐酸依替米星
1.
A HPLC method for determination of etimicin hydrochloride was presented.
以邻苯二甲醛为衍生试剂 ,用柱前衍生化高效液相色谱法测定盐酸依替米星的含量。
6) 5'-epi-etimicin
5'-差向依替米星
补充资料：依泽替米贝
分子式：C24H21F2NO3
分子量：409.43
CAS号：163222-33-1
性质：
分子量：409.43
CAS号：163222-33-1
性质：
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条